Partner Ehsun Forghany was quoted by CosmeticsDesign USA on how industry stakeholders should revisit and revise their intellectual property (IP) strategies after the May 2 closure of the de minimis loophole.
Chairman Anthony Lupo and Consumer Products Group Co-Leader Michelle Mancino Marsh were quoted on how attorneys play a pivotal role behind the scenes at the Met Gala, one of the world’s premier fashion events.
Customs & Import Compliance Practice Leader Angela Santos was quoted on how importers are strategizing to lessen their liability under the Trump Administration’s tariffs.
Gayland Hethcoat was quoted on the potential for increased data privacy litigation targeting health plans, with the Blue Shield case possibly sparking a “broader wave” of lawsuits.
Partner Emily Cowley Leongini was quoted on the federal court decision regarding the oversight of laboratory-developed tests by the US Food and Drug Administration.
In a recent discussion at SupplySide Connect in Secaucus, Associate Mario Torrico addressed the impact of tariffs on global supply chains.
Consumer Products Co-Leader Katia Asche discussed California’s Assembly Bill 728, which seeks to ban the sale of over-the-counter skincare products containing retinol and alpha hydroxy acid (AHA) to minors under the age of 18.
The Consulate General of Finland featured Partner Jon Jurva, Finnish Honorary Consul in Chicago, highlighting his contributions to supporting diplomatic and cultural ties between Finland and the United States.
Partner David Greenberg was quoted on a series of patient lawsuits challenging the alleged use of artificial intelligence (AI) and algorithms by health insurers, commenting on the potential hazards of insurers using the technology.
Partner David Dubrow was quoted on the use of artificial intelligence in fraud in response to the US Securities and Exchange Commission’s (SEC) complaint against three individuals who allegedly use fake documents to defraud investors in municipal bonds.
James Kim was quoted on how the Trump Administration’s new 25% tariffs on cars and auto parts are prompting automakers and suppliers to reassess the North American automotive supply chain.
Health Care Partner Hillary Stemple was recently quoted on how physicians and other providers can navigate visits from drug and device manufacturer representatives, highlighting the legal and ethical complexities involved.
Health Care Practice Leader Douglas A. Grimm was quoted by Relias Media, urging hospitals and health care providers to prepare for potential Immigration and Customs Enforcement raids at their locations, following the Trump administration’s revocation of policies that previously made hospitals off-limits for immigration enforcement.
Partner J. Michael Showalter was quoted on President Donald Trump’s new policy invoking Rule65(c) of the Federal Rules of Civil Procedure as a litigation-deterrence strategy.
Partner Alexander Birkhold was quoted in a recent discussion on the effectiveness of “click-through training,” referring to trainings using click-through screens and multiple-choice tests, in corporate compliance training.
Proposed settlement requires Leader and its Canadian parent company, AutoCanada, to turn over $20 million, include full offering price in ads, and get consent for all charges.
Health Care Practice Leader Douglas A. Grimm was quoted by Law360, urging hospital leaders and lawyers across the country to start implementing new strategies after the Trump Administration pulled back a Biden Administration 2021 directive to avoid immigration enforcement at certain locations, including hospitals.
In his published article, “The Corporate Transparency Act Whipsaw Continues,” Partner Evgeny Magidenko provides an in-depth analysis of the current legal landscape surrounding the Corporate Transparency Act (CTA) following a series of judicial decisions.
On December 12, the US Food and Drug Administration (FDA) announced the availability of updated final guidance on cosmetic facility registration and cosmetic product listing. If you are experiencing déjà vu, you are not alone — the FDA announced the issuance of the same final guidance almost exactly one year ago, on December 18, 2023.
Health Care Practice Leader Douglas A. Grimm was quoted by Law360 discussing the lack of regulation surrounding the use of AI within health care.
Health Care Partner Jill A. Steinberg was quoted by Bloomberg Law on the expected difficulties in finding associational standing following the US Supreme Court’s dismissal of a challenge regarding standing against the US Food and Drug Administration.
In an interview with Harvard Law School, AFS Chairman Anthony V. Lupo talked about his role in helping shape the rise of fashion and retail law, AFS’s unique culture, and new legal industry trends to anticipate.
Presently, there is no overarching federal law or regulatory scheme specific to the unique challenges of AI. This places AI regulation on track to follow the same path as privacy/data collection—with the states, the courts, the industry itself, and other jurisdictions trying to fill the void.
The nation’s car dealerships experienced total losses of more than $1 billion as the result of a nationwide hacking and ransomware attack on their software and systems last month.
Customs Practice Leader and AFS Forced Labor Task Force Leader Angela M. Santos was quoted regarding the recent US Department of Homeland Security Uyghur Forced Labor Prevention Strategy Update.